COVID-19: Clinical Course and Outcome of the Disease in Patients on Hemodialysis

Authors

  • Ivan Zeljko SKB Mostar
  • Boris Rogić
  • Monika Tomić
  • Ivan Tomić
  • Ivona Ivančić
  • Inge Klupka-Sarić

Keywords:

COVID-19, hemodialysis, lactate dehydrogenase, SARS-CoV-2

Abstract

Background: This study investigated the relationship between inflammatory parameters and comorbidities, and mortality in patients on hemodialysis with COVID-19, to determine which parameters could be used as predictors of a clinical outcome.

Methods: Sixty-eight hemodialysis patients were included, who had COVID-19. We examined comorbidities, laboratory findings (first day and seven days after a positive PCR test), symptoms, and demographic factors regarding the outcome.

Main findings: A total of 70% of patients were hospitalized. The results showed that hypertension significantly contributed to a fatal outcome. The non-survivor group had significantly higher levels of CRP, WBC, and procalcitonin after seven days, and LDH basally and after seven days.

Principal conclusions: Patients who died from COVID-19 had significantly higher levels of CRP, WBC, and procalcitonin seven days after a positive test, and LDH initially and after seven days. It was shown that the value of LDH can serve as a prognostic factor in the severity of the disease and the possible fatal outcome

 

Downloads

Published

2023-12-28

How to Cite

1.
Zeljko I, Rogić B, Tomić M, Tomić I, Ivančić I, Klupka-Sarić I. COVID-19: Clinical Course and Outcome of the Disease in Patients on Hemodialysis. ABCR [Internet]. 2023 Dec. 28 [cited 2024 Apr. 19];2(2):135-40. Available from: http://abcr-mefmo.org/index.php/abcr/article/view/34

Issue

Section

Original articles

Categories